(Q35207408)

7 August 2017

0 references

1 reference

title

Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials (English)

1 reference

7 August 2017

1 reference

1 reference

1 reference

Jianping Liu

1

1 reference

7 August 2017

Minghui Zhu

series ordinal

2

1 reference

7 August 2017

Rui Shi

series ordinal

3

1 reference

7 August 2017

Min Yang

series ordinal

4

1 reference

7 August 2017

publication date

1 January 2003

1 reference

The American Journal of Chinese Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

31

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

337-354

1 reference

Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: a study on the anti-hepatitis B virus mechanism of oxymatrine

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

Current therapeutic trends in therapy for chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

The discovery of the hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

Do certain countries produce only positive results? A systematic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X03001107

A randomized controlled trial of kurorinone versus interferon-alpha2a treatment in patients with chronic hepatitis B

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1142/S0192415X03001107

Identifiers

DOI

10.1142/S0192415X03001107

1 reference

7 August 2017

1 reference